Mark Johnson

2.5k total citations
53 papers, 1.8k citations indexed

About

Mark Johnson is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Mark Johnson has authored 53 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 10 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Mark Johnson's work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (9 papers). Mark Johnson is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (9 papers). Mark Johnson collaborates with scholars based in United States, United Kingdom and Canada. Mark Johnson's co-authors include Ronen Gurvitch, John G. Webb, Fabian Nietlispach, Namal Wijesinghe, Christopher Thompson, Jonathon Leipsic, Jian Ye, David Wood, Anson Cheung and Robert Moss and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and American Journal of Psychiatry.

In The Last Decade

Mark Johnson

52 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Johnson United States 22 859 716 295 289 266 53 1.8k
Cathy A. Jenkins United States 26 429 0.5× 596 0.8× 300 1.0× 314 1.1× 309 1.2× 91 1.8k
Arnaud D. Kazé United States 21 274 0.3× 313 0.4× 237 0.8× 125 0.4× 284 1.1× 62 1.6k
Siu‐Fai Lui Hong Kong 29 429 0.5× 705 1.0× 125 0.4× 469 1.6× 663 2.5× 127 3.5k
Shao‐Wei Chen Taiwan 26 458 0.5× 1.1k 1.6× 61 0.2× 489 1.7× 582 2.2× 165 2.1k
Anastase Dzudié Cameroon 24 542 0.6× 1.2k 1.6× 237 0.8× 363 1.3× 182 0.7× 175 2.3k
David C. Rhew United States 21 641 0.7× 296 0.4× 253 0.9× 226 0.8× 241 0.9× 34 1.6k
Jonathan E. Gottlieb United States 16 751 0.9× 142 0.2× 413 1.4× 750 2.6× 400 1.5× 40 2.3k
C Rey Spain 23 640 0.7× 172 0.2× 67 0.2× 764 2.6× 351 1.3× 164 1.9k
Apurva Badheka United States 21 622 0.7× 1.2k 1.7× 234 0.8× 121 0.4× 453 1.7× 49 1.9k
Mahmoud U. Sani Nigeria 18 364 0.4× 777 1.1× 149 0.5× 209 0.7× 153 0.6× 76 1.4k

Countries citing papers authored by Mark Johnson

Since Specialization
Citations

This map shows the geographic impact of Mark Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Johnson more than expected).

Fields of papers citing papers by Mark Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Johnson. The network helps show where Mark Johnson may publish in the future.

Co-authorship network of co-authors of Mark Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Johnson. A scholar is included among the top collaborators of Mark Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Johnson. Mark Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foster, Ashley A., Jennifer A. Hoffmann, Hilary A. Hewes, et al.. (2024). Association of emergency department characteristics with presence of recommended pediatric‐specific behavioral health policies. SHILAP Revista de lepidopterología. 5(5). e13266–e13266. 1 indexed citations
2.
Zhang, Ying, et al.. (2023). Open‐label, drug–drug interaction study between the HIV‐1 maturation inhibitor GSK3640254 and a metabolic probe cocktail in healthy participants. British Journal of Clinical Pharmacology. 89(7). 2236–2245. 1 indexed citations
3.
4.
Herman, Geoffrey, et al.. (2021). Cultivating not gatekeeping: a key leadership role in the creative process. BMJ Leader. 5(1). 9–13. 2 indexed citations
5.
Weller, S, Julie Borland, Shuguang Chen, et al.. (2013). Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment. European Journal of Clinical Pharmacology. 70(1). 29–35. 48 indexed citations
6.
Levine, Daniel S., et al.. (2011). Real-World Estimated Effective Radiation Doses From Commonly Used Cardiac Testing and Procedural Modalities. Canadian Journal of Cardiology. 27(5). 613–618. 16 indexed citations
7.
Gurvitch, Ronen, John G. Webb, Ren Yuan, et al.. (2011). Aortic Annulus Diameter Determination by Multidetector Computed Tomography. JACC: Cardiovascular Interventions. 4(11). 1235–1245. 142 indexed citations
8.
Wetterneck, Tosha B., James M. Walker, Mary Ann Blosky, et al.. (2011). Factors contributing to an increase in duplicate medication order errors after CPOE implementation. Journal of the American Medical Informatics Association. 18(6). 774–782. 88 indexed citations
9.
Webb, John G., David Wood, Jian Ye, et al.. (2010). Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves. Circulation. 121(16). 1848–1857. 345 indexed citations
10.
Nietlispach, Fabian, Mark Johnson, Robert R. Moss, et al.. (2010). Transcatheter Closure of Paravalvular Defects Using a Purpose-Specific Occluder. JACC: Cardiovascular Interventions. 3(7). 759–765. 91 indexed citations
11.
Gurvitch, Ronen, David Wood, Jonathon Leipsic, et al.. (2010). Multislice Computed Tomography for Prediction of Optimal Angiographic Deployment Projections During Transcatheter Aortic Valve Implantation. JACC: Cardiovascular Interventions. 3(11). 1157–1165. 106 indexed citations
12.
Varma, Niraj & Mark Johnson. (2009). Prevalence of Cancelled Shock Therapy and Relationship to Shock Delivery in Recipients of Implantable Cardioverter‐Defibrillators Assessed by Remote Monitoring. Pacing and Clinical Electrophysiology. 32(s1). S42–6. 21 indexed citations
13.
Dawes, Donald M., et al.. (2008). 15-Second conducted electrical weapon exposure does not cause core temperature elevation in non-environmentally stressed resting adults. Forensic Science International. 176(2-3). 253–257. 29 indexed citations
14.
Iles‐Smith, Heather, Ya‐Chi Chen, Odin Naderer, et al.. (2007). Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end‐stage renal failure. British Journal of Clinical Pharmacology. 64(6). 738–744. 8 indexed citations
15.
Ford, Susan L., Y. Sunila Reddy, Sharon C. Murray, et al.. (2006). Single-Dose Safety and Pharmacokinetics of Brecanavir, a Novel Human Immunodeficiency Virus Protease Inhibitor. Antimicrobial Agents and Chemotherapy. 50(6). 2201–2206. 17 indexed citations
16.
Ji, Jiang, et al.. (1999). The pharmacokinetics of lamivudine in healthy Chinese subjects. British Journal of Clinical Pharmacology. 48(2). 250–253. 5 indexed citations
17.
Brandt, Keith, Gregory R. D. Evans, Mark Johnson, et al.. (1999). The Effects of Cisplatinum and Vincristine on Peripheral Nerve Regeneration. Plastic & Reconstructive Surgery. 104(2). 464–469. 6 indexed citations
18.
Johnson, Mark, et al.. (1998). The pharmacokinetics of lamivudine in patients with impaired hepatic function. European Journal of Clinical Pharmacology. 54(4). 363–366. 30 indexed citations
19.
Johnson, Mark, et al.. (1998). Single dose pharmacokinetics of lamivudine in subjects with impaired renal function and the effect of haemodialysis. British Journal of Clinical Pharmacology. 46(1). 21–27. 47 indexed citations
20.
Johnson, Mark, et al.. (1982). Abnormal endometrial echoes: sonographic spectrum of endometrial pathology.. Journal of Ultrasound in Medicine. 1(4). 161–166. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathy A. Jenkins Breakdown of academic impact, for papers by Arnaud D. Kazé Breakdown of academic impact, for papers by Siu‐Fai Lui Breakdown of academic impact, for papers by Shao‐Wei Chen Breakdown of academic impact, for papers by Anastase Dzudié Breakdown of academic impact, for papers by David C. Rhew Breakdown of academic impact, for papers by Jonathan E. Gottlieb Breakdown of academic impact, for papers by C Rey Breakdown of academic impact, for papers by Apurva Badheka Breakdown of academic impact, for papers by Mahmoud U. Sani
Rankless by CCL
2026